Nebu-Flow, an advanced aerosol drug-delivery company, has been selected as an Innovate UK Scaleup Programme company, joining a highly competitive national programme supporting innovation-driven businesses on their journey to international growth.

The designation places Nebu-Flow among a select group of high-potential ventures receiving strategic, director-level support to accelerate technical, regulatory and commercial scale-up. The programme provides access to a specialist Scaleup Board and experienced Scaleup Directors who operate together as a virtual executive team, helping companies take decisive steps toward investment readiness and global expansion

As part of the programme, Nebu-Flow will work closely with Innovate UK’s scale-up team to strengthen two core value drivers for investors. ISO 13485 readiness, including structured pre-audit preparation to support future medical-device regulatory submissions and a global IP roadmap, protecting Nebu-Flow’s growing portfolio of inhalation and aerosol-engineering technologies

This support will help Nebu-Flow refine its operational systems, strengthen quality and regulatory foundations, and sharpen commercial positioning as it prepares for its next phase of growth. This includes aligning its quality management system with medical-device requirements, securing IP assets across priority markets, and ensuring the platform is fully investor-ready.